(Q37179033)

18 August 2017

1 reference

title

A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders (English)

1 reference

18 August 2017

0 references

0 references

1 reference

1

Norbert Müller

1 reference

18 August 2017

Markus J Schwarz

2

1 reference

18 August 2017

1 June 2008

1 reference

European Archives of Psychiatry and Clinical Neuroscience

18 August 2017

1 reference

18 August 2017

258 Suppl 2

1 reference

18 August 2017

97-106

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-008-2012-3

18 August 2017

0 references

cites work

Plasma and platelet excitatory amino acids in psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-2012-3

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-2012-3

Beyond monoamines: glutamatergic function in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-2012-3

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-2012-3

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-2012-3

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-2012-3

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

12 December 2020

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

1 reference

12 December 2020

Different immune patterns in melancholic and non-melancholic major depression

1 reference

12 December 2020

Exposure to Prenatal and Childhood Infections and the Risk of Schizophrenia

1 reference

12 December 2020

Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients

1 reference

12 December 2020

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation

1 reference

12 December 2020

Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells.

1 reference

12 December 2020

Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration

1 reference

12 December 2020

Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders.

1 reference

12 December 2020

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

1 reference

12 December 2020

Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia.

1 reference

12 December 2020

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

12 December 2020

Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation

1 reference

12 December 2020

Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats.

1 reference

12 December 2020

Effect of rofecoxib on nociception and the serotonin system in the rat brain

1 reference

12 December 2020

Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.

1 reference

12 December 2020

A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation

1 reference

12 December 2020

Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms

1 reference

12 December 2020

Maternal infections and subsequent psychosis among offspring.

1 reference

12 December 2020

Neurokynurenines (NEKY) as common neurochemical links of stress and anxiety

1 reference

12 December 2020

Increased level of salivary prostaglandins in patients with major depression

1 reference

12 December 2020

Amantadine as augmentation therapy in the management of treatment-resistant depression

1 reference

12 December 2020

Major depressive disorder is associated with elevated monocyte counts

1 reference

12 December 2020

Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease

1 reference

12 December 2020

Cytokines production in chronic schizophrenia patients with or without paranoid behaviour.

1 reference

12 December 2020

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

12 December 2020

NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.

1 reference

12 December 2020

An open-label trial of riluzole in patients with treatment-resistant major depression

1 reference

12 December 2020

Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats

1 reference

12 December 2020

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

1 reference

12 December 2020

Cytokine-induced sickness behavior: where do we stand?

1 reference

12 December 2020

Riluzole augmentation for treatment-resistant depression

1 reference

12 December 2020

Cytokines and major depression

1 reference

12 December 2020

Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion.

1 reference

12 December 2020

Depression and immunity: a meta-analytic review

1 reference

12 December 2020

Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders.

1 reference

12 December 2020

Depression, immunocompetence, and prostaglandins of the E series

1 reference

12 December 2020

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

12 December 2020

Childhood central nervous system infections and risk for schizophrenia

1 reference

12 December 2020

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

1 reference

12 December 2020

[CSF Filtration as Experimental Therapy in Therapyresistant Psychoses in Borna Disease Virus-Seropositive Patients]

1 reference

12 December 2020

Childhood meningitis, brain maturation and the risk of psychosis

1 reference

12 December 2020

Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients

1 reference

12 December 2020

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.

1 reference

12 December 2020

An evaluation of the role of extracellular amino acids in the delayed neurodegeneration induced by quinolinic acid in the rat striatum.

1 reference

12 December 2020

A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.

1 reference

12 December 2020

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

1 reference

12 December 2020

Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages

1 reference

12 December 2020

Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques

1 reference

12 December 2020

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

1 reference

12 December 2020

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

1 reference

12 December 2020

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.

1 reference

12 December 2020

Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus

1 reference

12 December 2020

Neuropharmacology of quinolinic and kynurenic acids

1 reference

12 December 2020

Urinary excretion of biopterin and neopterin in psychiatric disorders

1 reference

12 December 2020

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

1 reference

12 December 2020

Tolerance, DCs and tryptophan: much ado about IDO

1 reference

12 December 2020

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

12 December 2020

Cyloserine as an antidepressant agent

1 reference

12 December 2020

Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers.

1 reference

12 December 2020

Cytokine-associated emotional and cognitive disturbances in humans

1 reference

12 December 2020

Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status

1 reference

12 December 2020

Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population.

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

Elevated plasma prostaglandin E2 levels in schizophrenia

1 reference

12 December 2020

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

12 December 2020

Possible use of amantadine in depression

1 reference

12 December 2020

Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring

1 reference

12 December 2020

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

1 reference

12 December 2020

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

12 December 2020

Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain.

1 reference

12 December 2020

Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects.

1 reference

12 December 2020

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

1 reference

12 December 2020

Clinical effects of COX-2 inhibitors on cognition in schizophrenia.

1 reference

12 December 2020

T-helper-1 and T-helper-2 responses in psychiatric disorders

1 reference

12 December 2020

The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats.

1 reference

12 December 2020

Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat.

1 reference

12 December 2020

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

12 December 2020

Immune correlates of depression.

1 reference

12 December 2020

Effects of MK-801 and antidepressant drugs in the forced swimming test in rats

1 reference

12 December 2020

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

1 reference

12 December 2020

Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes

1 reference

12 December 2020

Indicators of immune activation in major depression

1 reference

12 December 2020

Increased CD56+ natural killer cells and related cytokines in major depression

1 reference

12 December 2020

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

1 reference

12 December 2020

Antidepressant effect of ketamine during ECT.

1 reference

12 December 2020

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

12 December 2020

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

1 reference

12 December 2020

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

1 reference

12 December 2020

Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function

1 reference

12 December 2020

Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims

1 reference

12 December 2020

The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase

1 reference

12 December 2020

Immune and hormonal activity in adults suffering from depression

1 reference

12 December 2020

Effect of monoamine reuptake inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis (EAN)

1 reference

12 December 2020

Increased serum glutamate in depressed patients

1 reference

12 December 2020

CSF 5-HIAA predicts suicide risk after attempted suicide

1 reference

12 December 2020

Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment

1 reference

12 December 2020

The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders

1 reference

12 December 2020

Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia

1 reference

12 December 2020

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

1 reference

12 December 2020

Serologic evidence of prenatal influenza in the etiology of schizophrenia

1 reference

12 December 2020

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

12 December 2020

Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus

1 reference

12 December 2020

Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals

1 reference

12 December 2020

10.1007/S00406-008-2012-3

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18516521